Figure 1: Lung biopsy and genetic testing occurrences by primary
disease category.
A. Data is based on the 110 unique patients, 35.9% of the overall
cohort, who underwent lung biopsy. B. Data is based on the 149 unique
patients, 48.7% of the overall cohort, who underwent genetic testing.
NEHI: Neuroendocrine cell Hyperplasia of Infancy; ILD NOS: interstitial
lung disease not otherwise specified